| |
Article Title |
Author(s) |
Pages |
|
|
|
Editorial Board
|
|
iii
|
|
|
|
CCL Doppler Echocardiography in Diastology: 35 Years of Japanese Contribution to its Advancement and Utility
|
Akira Kitabatake,
Satoshi Nakatani,
Hisao Onozuka,
Taisei Mikami
|
S1
|
|
|
|
WHF1-1 Global Burden of Cardiovascular Disease: Challenges Ahead
|
Shahryar Sheikh
|
S1
|
|
|
|
WHF1-2 Primary and Secondary Prevention of Heart Failure
|
Mario F. de Camargo Maranhão
|
S1-S2
|
|
|
|
WHF1-3 Location of MI with Q Wave in the Era of Cardiac Imaging Techniques
|
A. Bayés de Luna
|
S2
|
|
|
|
WHF2-1 Diastolic Heart Failure; A Medical Creation or Management Problem
|
Philip A. Poole-Wilson
|
S2-S3
|
|
|
|
WHF2-2 Herbal Prescription for Cardio-Vascular Health
|
Tak-Fu Tse
|
S3
|
|
|
|
WHF2-3 Aging & Cardiovascular Disease in Asia
|
David T. Kelly
|
S3
|
|
|
|
SL1 Progression of Cardiovascular Disease: A New Therapeutic Target
|
Jay N. Cohn
|
S3
|
|
|
|
SL2 Cardiac Imaging in Systolic and Diastolic Heart Failure
|
Jae K. Oh
|
S3
|
|
|
|
SL3 A New Strategy for the Management of Atrial Fibrillation
|
Satoshi Ogawa
|
S3-S4
|
|
|
|
SL4 Global Alert and Response Network for Hepatitis C Virus-Derived Heart Diseases
|
Akira Matsumori
|
S4
|
|
|
|
SL5 Severe Asymptomatic Valvular Regurgitation: Choosing the Golden Moment for Operation
|
A. Jamil Tajik
|
S4
|
|
|
|
SL6 State-of-the-Art: Interventional Echocardiography
|
Cheng-Wen Chiang
|
S4
|
|
|
|
SL7 Clinical Value of Coronary Flow Velocity Measurement by Transthoracic Doppler Echocardiography
|
Junichi Yoshikawa
|
S4-S5
|
|
|
|
SL8 Waon Therapy for Cardiovascular Disease: An Ideal Therapy for the Patients
|
Chuwa Tei
|
S5
|
|
|
|
SL9 Management of the Patient with an “ICD Storm”
|
Koonlawee Nademanee
|
S5
|
|
|
|
SS-1 Asian-Pacific Congress of Cardiology (APCC) from Birth to the Present
|
Chuichi Kawai
|
S5-S6
|
|
|
|
SS-2 Future Perspective of the APSC
|
Noe A. Babilonia
|
S6
|
|
|
|
SS-3 Current Challenges and Future Perspective of APSC
|
Anil Kumar
|
S6
|
|
|
|
JS1-1 Smokeless Tobacco in the US, EU, and JAPAN
|
Takashi Hanioka
|
S6
|
|
|
|
JS1-2 Tobacco Control in Japan
|
Keijiro Saku
|
S6-S7
|
|
|
|
JS1-3 Effective Tobacco Control: Roles and Responsibilities for Today's Cardiologists
|
Edgardo Ulysses N. Dorotheo
|
S7
|
|
|
|
JS1-4 Smoking Cessation: More Quit Attempts More Often
|
Tony Duncan
|
S7
|
|
|
|
JS2-1 Adapting the “Go Red for Women” to Japan
|
Keiko Amano
|
S7
|
|
|
|
JS2-2 Risk Factors and Clinical Presentation of CHD in Women
|
Mónica Acevedo
|
S7
|
|
|
|
JS2-3 The Myth about Cardiovascular Disease as a Male Disease and its Consequences for Women's Hearts
|
Susanne Volqvartz
|
S8
|
|
|
|
JS3-1 Who to Treat? How to Treat? Sleep Disordered Breathing in Cardiovascular Disease in Japan
|
Koji Narui
|
S8
|
|
|
|
JS3-2 Obstructive Sleep Apnea and Endothelial Dysfunction
|
Mary Ip
|
S8
|
|
|
|
JS3-3 Obstructive Sleep Apnea and Metabolic Syndrome
|
K Chin
|
S8-S9
|
|
|
|
JS3-4 Pathogenesis and Treatment of Sleep Apnoea in Heart Failure
|
Matthew T. Naughton
|
S9
|
|
|
|
JS3-5 Sleep Disordered Breathing in Heart Failure Patients
|
Takatoshi Kasai
|
S9
|
|
|
|
JS4-1 Mechanism of Enterovirus Persistence in Human Heart Disease
|
Nora M. Chapman
|
S9
|
|
|
|
JS4-2 Diagnosis and Treatment of Chronic Viral Cardiomyopathy (CVC)
|
Heinz-Peter Schultheiss
|
S9-S10
|
|
|
|
JS4-3 Evaluation of Increased Level of NT-proBNP in Viral Hepatitis Patients in China
|
Ling Wang,
Yibin Chang,
Akira Matsumori,
Hui Zhuang
|
S10
|
|
|
|
JS4-4 Hepatitis C Virus Heart Diseases in Egypt
|
Mohammad Abdel-Nabi Haykal,
H. Negm,
S. Al Hawary,
O. Kaid,
E. Negm,
I. Shawky
et al.
|
S10
|
|
|
|
JS5-1 Genetics and Mechanisms of Cardiomyopathy and Heart Failure: 21st Century Update
|
Jeffrey A. Towbin
|
S10-S11
|
|
|
|
JS5-2 Treatment of Viral and Autoreactive Inflammatory Cardiomyopathy
|
Bernhard Maisch
|
S11
|
|
|
|
JS5-3 Variant Types of Stress-Induced Cardiomyopathy
|
Kee-Sik Kim
|
S11
|
|
|
|
JS5-4 Advances in the Noninvasive and Immunohistological Diagnosis of Myocarditis
|
Leslie T. Cooper
|
S11
|
|
|
|
JS5-5 Heart Failure Therapy that Targets Nuclear Signaling Pathway in Cardiomyocytes
|
Koji Hasegawa
|
S11
|
|
|
|
S1-1 The Role and Regulation of Mineralocorticoid Receptor Activation in Heart Failure
|
Morag J. Young
|
S12
|
|
|
|
S1-2 Physiological and Pathophysiological Actions of Aldosterone to Cardiomyocytes
|
Michihiro Yoshimura
|
S12
|
|
|
|
S1-3 Effects of Aldosterone Blockade on Cardiac Renin Angiotensin-Aldosterone System in Salt-Sensitive Hypertension
|
Yoshiyu Takeda,
Aoshuang Zhu,
Takashi Yoneda
|
S12
|
|
|
|
S1-4 Effectiveness of Aldosterone Blockade in Patients with Hypertension and CKD
|
Atsuhisa Sato
|
S12-S13
|
|
|
|
S2-1 Assessment of Left Ventricular Systolic Function in Diastolic Heart Failure Using Cardiac Time Intervals
|
Akira Kisanuki,
Mihoko Kono,
Chuwa Tei
|
S13
|
|
|
|
S2-2 Assessment of Left Ventricular Diastolic Function by Novel Ultrasound Techniques
|
Satoshi Nakatani
|
S13
|
|
|
|
S2-3 Assessment of LV Function by 3D Echo
|
Tsui-Lieh Hsu
|
S13
|
|
|
|
S2-4 Echo, Small Coronary Artery Stenosis in HCM
|
Woo-Shik Kim
|
S13-S14
|
|
|
|
S3-1 miRNAs and Cardiac Arrhythmogenesis: Role in Atrial Fibrillation
|
Zhiguo Wang,
Baofeng Yang
|
S14
|
|
|
|
S3-2 MicroRNAs and Malignant Arrhythmias
|
Baofeng Yang,
Yanjie Lu,
Yong Zhang,
Yunlong Bai
|
S14
|
|
|
|
S3-3 Cardiomyocyte Death and Heart Failure
|
Kinya Otsu
|
S14
|
|
|
|
S3-4 Role of p53 in Heart Failure
|
Tohru Minamino,
Issei Komuro
|
S14-S15
|
|
|
|
S4-1 Connexin and Heart Failure
|
Hung-I Yeh
|
S15
|
|
|
|
S4-2 Gene Polymorphisms in Patients with Heart Failure and Acute Coronary Syndromes
|
V.A. Cameron,
A.P. Pilbrow,
B.R. Palmer,
K.L. Ellis,
J. Pearson,
C.S. Moravec,
W.E. Sweet,
W. Tang,
R.W. Troughton,
A.M. Richards
et al.
|
S15
|
|
|
|
S4-3 Characteristics of Gene Profiling in Failing Myocardium
|
Masanori Asakura,
Shin Ito,
Kyondok Min,
Yulin Liao,
Akiko Ogai,
Hiroshi Asanuma,
Jiyoong Kim,
Masafumi Kitakaze
et al.
|
S15
|
|
|
|
S4-4 Heart Failure and β-Blocker
|
Junichi Azuma
|
S15-S16
|
|
|
|
S5-1 What's New with Beta-Blockers
|
Henry Krum
|
S16
|
|
|
|
S5-2 Recent Progress in the Pharmacological Treatment of Heart Failure: Role of Angiotensin Receptor Blockers
|
Jeffrey W.H. Fung
|
S16
|
|
|
|
S5-3 Natrecor® (Nesiritide; Recombinant Human BNP) in Acute Decompensated Heart Failure
|
Dong-Ju Choi
|
S16
|
|
